, Tracking Stock Market Picks
Enter Symbol:
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

up 60.51 %

Auxilium Pharmaceuticals, Inc. (AUXL) rated Buy with price target $21 by Deutsche Bank

Posted on: Tuesday,  Nov 1, 2011  1:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 11/01/2011. Previously Deutsche Bank rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on
07/13/2010., when the stock price was $22.72. Since then, Auxilium Pharmaceuticals, Inc. has gained 60.52% as of 01/29/2015's recent price of $36.47.
If you would have followed the previous Deutsche Bank's recommendation on AUXL, you would have gained 60.51% of your investment in 1661 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/1/2011 1:25 PM Buy
14.79 21.00
as of 12/30/2011
1 Week up  2.20 %
1 Month up  14.34 %
3 Months up  32.95 %
1 YTD down  -5.54 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/13/2010 1:25 PM Buy
22.72 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy